Baxter (NYSE: BAX) reported Q2 EPS of $0.56, $0.19 better than the analyst estimate of $0.37. Revenue for the quarter came in at $2.96 billion versus the consensus estimate of $2.8 billion.

GUIDANCE:

Baxter sees FY2026 EPS of $1.95-$2.15, versus the consensus of $1.91.

For earnings history and earnings-related data on Baxter (BAX) click here.